---
link: https://www.statnews.com/2025/03/05/jazz-chimerix-acquisition-dordaviprone-brain-cancer/
---

Jazz Pharmaceuticals said Wednesday it would spend nearly $1 billion to buy Chimerix and its experimental pill for a devastating brain tumor that primarily affects children and young adults. Log in Monthly $39 Totals $468 per year Totals $468 per year Starter $30 for 3 months, then $399/year Then $399/year Annual $399 Save 15% Save 15% 11+ Users Custom Savings start at 25%! 2-10 Users $300 Annually per user $300 Annually per user 
						To read the rest of this story subscribe to STAT+.